Good afternoon.
The argument suggests that pharmaceutical companies would receive no compensation, but this is not true. Any waiver adopted by the WTO is accompanied by financial compensation. So the companies would still be compensated. As far as we know, there are a number of waivers pending at the WTO, and this has not prevented research and development.
In addition, public funding has been provided for the development of most vaccines. In this sense, one can now ask questions about how these vaccines are used. At least one can ask who can receive them, given the global situation. We are facing an exceptional pandemic, and it requires the implementation of exceptional measures.
The arguments put forward by Mr. Paquette are not helpful from a public health point of view. This is indeed the crux of the matter.
